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Original Article
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ABSTRACT
Background and Objectives: EUS‑guided biliary drainage (EUS‑BD) is a feasible procedure when ERCP fails, as is
percutaneous transhepatic BD (PTBD). However, little is known about patient perception and preference of EUS‑BD and
PTBD. Patients and Methods: An international multicenter survey was conducted in seven tertiary referral centers. In
total, 327 patients, scheduled to undergo ERCP for suspected malignant biliary obstruction, were enrolled in the study.
Patients received decision aids with visual representation regarding the techniques, benefits, and adverse events (AEs)
of EUS‑BD and PTBD. Patients were then asked the choice between the two simulated scenarios (EUS‑BD or PTBD)
after failed ERCP, the reasons for their preference, and whether altering AE rates would influence their prior choice.
Results: In total, 313 patients (95.7%) responded to the questionnaire and 251 patients (80.2%) preferred EUS‑BD.
The preference of EUS‑BD was 85.7% (186/217) with EUS‑BD expertise, compared to 67.7% (65/96) without EUS‑BD
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expertise (P < 0.001). The main reason for choosing EUS‑BD was the possibility of internal drainage (78.1%). In
multivariate analysis, the availability of EUS‑BD expertise was the single independent factor that influenced patient
preference (odds ratio: 3.168; 95% of confidence interval, 1.714–5.856; P < 0.001). The preference of EUS‑BD increased
as AE rates decreased (P < 0.001). Conclusions: In this simulated scenario, approximately 80% of patients preferred
EUS‑BD over PTBD after failed ERCP. However, preference of EUS‑BD declined as its AE rates increased. Further
technical innovations and improved proficiency in EUS‑BD for reducing AEs may encourage the use of this procedure
as a routine clinical practice when ERCP fails.
Keywords: Drainage, endosonography, patient preference, surveys and questionnaires

INTRODUCTION
ERCP with biliary drainage (BD) is a standard
procedure for malignant biliary obstruction.[1,2] However,
ERCP may fail in certain patients due to failed
transpapillary cannulation or an inaccessible papilla
caused by the duodenal invasion of the malignant
tumor.[3‑7] The failure rate of ERCP is reported to be
up to 7%,[8] and percutaneous transhepatic BD (PTBD)
is a conventional option in such cases. PTBD has been
demonstrated to have a high success rate (87%–100%).[9]
However, the requisite external catheter placement is
a major drawback, in addition to several adverse
events (AEs) including pneumothorax, hepatic arterial
injury, bile duct injury, and liver abscess.[10‑12] As a result,
many endoscopists sought to identify a less invasive
procedure than PTBD.
Since the first report by Giovannini et al. in 2001,[13]
EUS‑guided BD (EUS‑BD) has been reported to be
a feasible and effective BD procedure when ERCP
fails. EUS‑BD has been demonstrated to have a
technical success rate of approximately 90% and an
AE rate of 17%.[9,14‑18] It has specific advantages over
PTBD, as follows: (1) it can be performed in a single
session when ERCP has been unsuccessful, (2) it can
provide immediate internal drainage with less physical
discomfort,[19] and (3) it is potentially cost‑effective,
with fewer unscheduled reintervention over long‑term
follow‑up.[19,20] However, EUS‑BD requires experienced
endoscopists with advanced endoscopic capabilities and
appropriate radiological/surgical backup to manage
failed interventions and/or AEs.
Although endoscopists with EUS‑BD expertise may
prefer EUS‑BD over PTBD after failed ERCP due
to the potential benefits of EUS‑BD including a
possible one‑stage procedure in the same ERCP
unit and internal drainage, patient perception and
preference of EUS‑BD are not well understood.

Since patients’ medical knowledge was limited
and personal patient preference had not been
incorporated in medical decision‑making, it was
difficult to make patient‑centered decision in real
clinical practice. Recently, shared decision‑making
model between patient and physician has been
suggested, [21,22] and patient decision aids which help
appropriate informed choice has been evaluated. [23]
Eliciting the personal preference of the patient then
working to align these values and preference with
shared decision‑making strengthens the therapeutic
alliance and is more protective of the provider in a
medico‑legal context.[24] Poor communication by the
provider and inadequate knowledge on the part of
the patient are often precursors for medical liability
claim.[25]
The primary aim of this study was to determine
whether patients with suspected malignant biliary
obstruction enrolled prefer EUS‑BD or PTBD under
a simulated scenario (after failed ERCP) with decision
aids. The secondary aim was to assess whether altering
AEs rates in EUS‑BD influenced the patient selection
of EUS‑BD and/or PTBD.
PATIENTS AND METHODS

Study population

This study was an international multicenter
cross‑sectional survey of patients scheduled to undergo
ERCP for suspected malignant obstruction. Participation
in the study was voluntary, and compensation was not
provided. An informational booklet describing EUS‑BD
and PTBD as rescue procedures when ERCP fails,
which contained details of the techniques, benefits,
and AEs relating to each procedure was provided to
the study participants. Once the informational booklet
was read, the survey was administered to consecutive
patients.
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Seven tertiary referral centers in South Korea, Japan,
and Spain were participated in this study. Of these,
EUS‑BD was available in five centers, and PTBD was
available at all of them. Participants who preferred
EUS‑BD were informed as to whether EUS‑BD could
be performed at their center. Along with the survey,
informed consent to undergo any of the available BD
procedures (ERCP, EUS‑BD, and PTBD) was obtained
from the patients before ERCP. The institutional review
board for each institution approved the study protocol.

Informational booklet and survey

A third party in the United States created the
informational booklet [Supplementary Appendix 1] with
visual aids and questionnaire [Supplementary Appendix 2]
to minimize selection bias with respect to the
endoscopists. The survey was simplified using a subject
choice followed by an explanation choice model, and it
was written in easily understandable 5th grade US English
for patients without medical knowledge. In an attempt
to create a reliable and valid questionnaire, the survey
was first administered to 34 3rd‑year medical students
at the University of Ulsan College of Medicine, Seoul,
South Korea, and pilot‑tested for clarity and internal
consistency [Supplementary Appendix 3]. As a result,
the questionnaire demonstrated high internal consistency,
with a Cronbach’s α value of 0.82. The forms then were
translated into Korean, Japanese, and Spanish.
The survey was administered to the participants by
trained research assistants who read from a standardized
script. The patients were allowed sufficient time to read
the information booklet and complete the questionnaire.
A detailed explanation or discussion of each procedure
was not permitted to minimize the risk of selection
bias. It was clearly stated that the patient’s preference
would not be disclosed to the attending physician and
it would not affect the treatment plan. The results were
blinded to ensure patient anonymity.
The questionnaire started with questions on age,
sex, ethnicity, and prior endoscopy, ERCP, and
PTBD [Supplementary Appendix 2]. First, participants
were questioned as to their preference of a rescue
procedure (EUS‑BD or PTBD) to be performed in
the event of failed ERCP and were asked to provide
the reasons for their preference. Choice options listed
for EUS‑BD were as follows: (1) It can be done at
the same time during the ERCP, so you do not have
to come back again for another procedure, (2) It has a
higher success rate and relatively low AEs, and (3) It
50

is comfortable, so you do not have drain tube through
the skin (such as PTBD). Choice options listed for a
PTBD were as follows: (1) It takes less time to place
it (quicker), (2) It is cheaper, (3) It is safer (lower AEs),
and (4) It is more convenient (easy to perform for the
operator). Patients were also permitted to write down
any unlisted reasons for their preference.
Patients were then asked whether their opinion would
change depending on altering AE rates of EUS‑BD
compared to those of PTBD (9%–33%). To reduce
the chance of selection bias among EUS‑BD experts,
two centers without EUS‑BD experts (two South Korean
centers), three centers with EUS‑BD experts
(one South Korea center and two Spanish centers),
and two centers with experts in both EUS‑BD and
PTBD (two Japanese centers) were invited to participate.

Statistical analyses

The participants were divided into two groups
according to the procedure of their choosing (EUS‑BD
vs. PTBD). Statistical analysis was performed using
SPSS software version 21.0 (SPSS Inc., Chicago, IL).
Continuous variables were reported as the mean and
standard deviation and were compared between the
groups using the unpaired t‑test. Categorical variables
were reported as frequencies and percentages and
were evaluated using Fisher’s exact test. The value of
P < 0.05 was considered to be statistically significant.
To calculate the sample size, it was assumed that
two‑thirds (66%) of the sample would prefer EUS‑BD.
A sample size of 75 was identified to determine
whether this proportion was significantly different from
50% a priori, with an alpha of 0.05 and a power of
80%. Assuming a 30% response rate, we planned to
recruit 350 patients (50 patients from each institution).
RESULTS
In total, 327 patients who were scheduled to undergo
ERCP due to suspected malignant biliary obstruction
were recruited and of these, 313 patients completed
the questionnaire (response rate: 95.7%) [Figure 1].
The demog raphic characteristics of the study
participants are shown in Table 1. The mean age
was 64 years (range: 34–88 years), and 182 of the
respondents (58.1%) were male. The suspected
diagnoses of the respondents based on imaging
studies (abdominopelvic computed tomog raphy
and/or magnetic resonance cholangiopancreatography)
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For the second question, preference of EUS‑BD
decreased as AE rates increased (P < 0.001).
Two‑hundred and one of 217 participants (92.6%) at
the five centers with EUS‑BD expertise were willing to
undergo PTBD if AE rates of EUS‑BD were higher
than those of PTBD (range: 9%–33%). In contrast,
if AE rates of EUS‑BD were lower when compared
to those of PTBD, 93 of 96 participants (96.9%)
at the two centers without EUS‑BD expertise
were willing to undergo EUS‑BD. There was no
significant difference in patient preference based on
AE rates of EUS‑BD according to the availability
of EUS‑BD expertise [Figure 3a] or the region
(Asia vs. Europe) [Figure 3b].
Figure 1. Flow diagram for study

were cholangiocarcinoma in 101 (32.3%), gallbladder
cancer in 25 (8%), ampullary cancer in 20 (6.4%),
pancreatic head cancer in 93 (29.7%), hepatocellular
carcinoma in seven (2.2%), metastatic lymph node
in five (1.6%), and indeterminate biliary stricture in
62 (19.8%).
Among these, 258 patients (82.4%) had previously
undergone endoscopy, 163 patients (52.1%) had
undergone ERCP, and 55 patients (17.6%) had
undergone PTBD. There were no differences in
preference between EUS‑BD and PTBD within three
subgroups. EUS‑BD was preferred by 186 of 217
participants (85.7%) at the five centers which EUS‑BD
was available, compared to 65 of 96 patients (67.7%)
at the two centers which it was unavailable (P < 0.001).
There was no significant difference in preference of
EUS‑BD according to the region (Asia vs. Europe) or
race (Asian vs. non‑Asian) [Table 1].
In multivariate analysis, the availability of EUS‑BD
expertise was the single independent factor that
influenced patient preference (odds ratio [OR]
3.168; 95% of confidence interval [CI] 1.714–5.856;
P < 0.001) [Table 2]. Reasons for selecting
EUS‑BD included less physical discomfort without
percutaneous drain tube placement (196/251, 78.1%),
a higher success rate with relatively lower morbidity
(110/251, 43.8%), and the ability to be performed
at the same time as the ERCP (71/251, 28.3%).
By contrast, reasons for selecting PTBD included
proven technical safety (43/62, 69.4%), shorter
procedure time (18/62, 29%), technical easiness
(8/62, 12.9%), and cost‑effectiveness (4/62,
6.5%) [Figure 2].

DISCUSSION
To the best of our knowledge, this is the first study to
focus on the patient preference of BD procedures in
patients with suspected malignant biliary obstruction.
In this survey, most patients would prefer EUS‑BD to
PTBD when ERCP fails due to the ability to undergo
internal drainage without the need for a percutaneous
drain tube. Preference of EUS‑BD was significantly
higher at centers with EUS‑BD expertise compared to
centers without EUS‑BD expertise (85.7% vs. 67.7%,
respectively; P < 0.001). In multivariate analysis, the
availability of EUS‑BD expertise was significantly
associated with the preference of EUS‑BD (OR 3.168,
95% CI 1.714–5.856, P < 0.001). In addition, patient
willingness to undergo EUS‑BD was observed to
decline in the context of higher AE rates compared
to PTBD.
EUS‑BD has been reported to be a feasible BD
technique. In a recent randomized controlled trial,
EUS‑BD was compared with PTBD after failed ERCP
in patients with malignant biliary obstruction.[26] In
that study, EUS‑BD showed technical success rates
comparable to those of PTBD (94.1% vs. 96.9%,
respectively), and fewer AE rates compared to
PTBD (8.8% vs. 31.2%, respectively). Although detailed
data on EUS‑BD are limited, there are clear advantages
to EUS‑BD, including the possibility of internal
drainage without the placement of a percutaneous drain
tube, and the fact that EUS‑BD can be performed
in the same session after failed ERCP provided
appropriate informed consent is obtained.
In this study, before ERCP, patients were asked about
preferred BD procedure when ERCP fails. This
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Table 1. Baseline characteristics of patients and factors influencing the preference for EUS‑BD in
univariate analysis
Variable
Age (year), mean±SD
≥65
Sex
Male
Suspected diagnosis
Cholangiocarcinoma
Gallbladder cancer
Ampullary cancer
Pancreatic head cancer
Hepatocelluar carcinoma
Metastatic lymph node
Indeterminate biliary stricture
Prior experience
Prior endoscopy
Prior ERCP
Prior PTBD
Availability of EUS‑BD‑expertise
EUS‑BD‑expertise available
(Preference of EUS-BD)
EUS‑BD‑expertise unavailable
(Preference of EUS-BD)
Region
Asia
(Preference of EUS-BD)
Europe
(Preference of EUS-BD)
Race
Asian
(Preference of EUS-BD)
Non‑Asian (caucasian, hispanic)
(Preference of EUS-BD)

Total (n=313) (%)

Preferred EUS‑BD (n=251) (%)

Preferred PTBD (n=62) (%)

P

64.0±15.5
160 (51.1)

64.3±15.0
128 (51.0)

62.7±17.5
32 (51.6)

0.931

182 (58.1)

149 (59.4)

33 (53.2)

0.380

101 (32.3)
25 (8.0)
20 (6.4)
93 (29.7)
7 (2.2)
5 (1.6)
62 (19.8)

85 (33.9)
22 (8.8)
16 (6.4)
71 (28.3)
6 (2.4)
5 (1.9)
46 (18.3)

16
3
4
22
1
0
16

(25.8)
(4.8)
(6.5)
(35.5)
(1.6)
(0.0)
(25.8)

0.469

258 (82.4)
163 (52.1)
55 (17.6)

212 (84.5)
132 (52.6)
42 (16.7)

46 (74.2)
31 (50.0)
13 (21.0)

0.057
0.715
0.433

217 (69.3)
(100.0)
96 (30.7)
(100.0)

186 (74.1)
(85.7)
65 (25.9)
(67.7)

31 (50.0)
(14.3)
31 (50.0)
(32.3)

<0.001

241 (77.0)
(100.0)
72 (23.0)
(100.0)

197 (78.5)
(81.7)
54 (21.5)
(75.0)

44 (71.0)
(18.3)
18 (29.0)
(25.0)

0.208

242 (77.3)
(100.0)
71 (22.7)
(100.0)

198 (78.9)
(81.8)
53 (21.1)
(74.6)

44 (71.0)
(18.2)
18 (29.0)
(25.4)

0.183

EUS‑BD: EUS‑guided biliary drainage, PTBD: Percutaneous transhepatic biliary drainage, SD: Standard deviation

Table 2. Factors influencing the preference for
EUS‑guided biliary drainage in multivariate
logistic regression analysis
Variable
Sex (male vs. female)
Age (<65 years vs. ≥65 years)
Previous endoscopy (no
experience vs. experience)
EUS‑BD‑expertise availability
(unavailable vs. available)

OR

95% CI

P

0.853
0.710
1.887

0.479–1.518
0.386–1.307
0.955–3.728

0.588
0.272
0.068

3.168

1.714–5.856

<0.001

OR: Odds ratio, CI: Confidence interval, EUS‑BD: EUS‑guided biliary
drainage

process may simulate obtained informed consent for
possible EUS‑BD before ERCP. Since the prediction
of endoscopically inaccessible papilla before ERCP is
difficult, unplanned PTBD after failed outpatient ERCP
may occur, and it can incur additional hospitalization
and an unexpected economic burden on patients
and their families. Thus, we adopted an algorithm
52

Figure 2. Graph demonstrating the reasons behind patient preference

described in our previous studies,[16,18,26] and routinely
obtained informed consent for EUS‑BD before ERCP,
especially in patients at potential risk of unsuccessful
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a

b

Figure 3. Relationship between patient preference and adverse event rates for EUS‑guided biliary drainage depending on (a) the availability of
EUS‑guided biliary drainage expertise and (b) the region

cannulation. This approach allows the endoscopists to
perform timely, one‑stage BD, even in the event of the
unexpected inaccessible papilla, without the difficulty of
obtaining informed consent from the sedated patient in
the same ERCP unit.
Due to comparable safety and cost‑effectiveness
between the inpatient and outpatient procedures, many
endoscopists perform ERCP on an outpatient basis in
the United States.[27] However, unplanned admission
after outpatient ERCP was reported in 10.7%–25.1%
of the cases.[28,29] EUS‑BD has been reported to result
in less physical discomfort [19] and fewer frequent
unscheduled reintervention with prolonged hospital
stays, which are associated with economic burden,
than PTBD. [26] Thus, EUS‑BD after failed ERCP in
same endoscopic session may reduce the unplanned
admission in the outpatient setting of ERCP. Therefore,
treating patients with a preference of EUS‑BD prior
to ERCP may be more appealing to endoscopists with
EUS‑BD expertise in the United States who are able
to perform outpatient ERCP compared with inpatient
setting of ERCP in other country with time availability
of scheduled alternative BD procedure on a different
session in same day or next day after failed ERCP.
In the present study, age, sex, and prior experience of
endoscopy, ERCP, and PTBD were not significantly
associated with a preference of EUS‑BD. However, the
preference of EUS‑BD was lower at centers without
EUS‑BD expertise compared to centers with available
EUS‑BD expert [Figure 3a]. We believe that patients
at centers without EUS‑BD expertise preferred PTBD

over EUS‑BD because it was perceived to be a safe and
readily accessible procedure without an endoscopist with
EUS‑BD expertise or appropriate radiological/surgical
backup. Similarly, patients at centers with EUS‑BD
expertise preferred EUS‑BD over PTBD because it was
perceived to be a comfortable and readily accessible
endoscopic procedure. Given the close relationship
between preference of EUS‑BD and its availability
at their particular center, we believe that technical
advancements and access to EUS‑BD experts would
improve patient preference and perception of EUS‑BD
when ERCP fails.
Patient willingness to undergo EUS‑BD was shown
to increase when AE rates for EUS‑BD were less
compared to those of PTBD (9%–33%). This suggests
that patients may have a fundamentally favorable
perception of EUS‑BD, regardless of its availability
within a given center or their preference of PTBD.
In a previous study, patient perception of natural
orifice transluminal endoscopic surgery (NOTES),
a newly developed endoscopic technique similar to
EUS‑BD, were evaluated, [30] and the preference of
NOTES was observed to decrease with increased
procedural AEs when compared to a more proven
procedure (laparoscopic cholecystectomy). Similarly, in
our study, the preference of EUS‑BD decreased in
accordance with an increase in AE rates of EUS‑BD
compared to those of PTBD. In these circumstances,
the patient preference may be affected by the
perception of PTBD with proven technical safety and
easiness.
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We included both Asian and European patients to
minimize selection bias with respect to a specific
region. In the context of a decrease in AE rates of
EUS‑BD compared to those of PTBD (<9%), the
preferential tendency of EUS‑BD in Spanish patients
was higher than that in Asian patients without statistical
significance. However, with similar or increased AE
rates of EUS‑BD compared with those of PTBD, the
preferential tendency for EUS‑BD in Spanish patients
was lower than that in Asian patients [Figure 3b].
Differences in the culture and health‑care systems
between Asia and Europe might have influenced
patient preferential tendency of EUS‑BD and PTBD
according to the degree of AE rates in EUS‑BD.
Further investigation is necessary to understand these
differences.
The response rate to the questionnaire was very
high (95.7%). All of the participants were scheduled
to undergo ERCP for suspected malignant biliary
obstruction. These patients showed interest in the
detailed process of the ERCP that they would be
undergoing and were concerned about the need for
any subsequent procedures in the event of failed
ERCP. In general, patients with suspected malignancy
wanted to understand their disease and its treatment
options. In a previous report, the majority of patients
who underwent an EUS‑FNA for suspected pancreatic
cancer wished to receive the preliminary results on the
day of the procedure (96.6%).[31] Similarly, we found
that the participating patients in this study wished to
obtain more information on the proposed procedures.
The role of the patients are increasing in medical
decision‑making, and incorporation of patient
preference into treatment is recommended in the
context of shared decision‑making.[23] It is reported that
shared decision‑making process may improve treatment
outcome, patient adherence, quality of care, and reduce
costs.[21,22] Although the relationship between patient
preference and choice of treatment options was not
evaluated in this study, our informational booklet may
be useful as a patient decision aid to the patients with
malignant biliary obstruction when ERCP fails. Further
studies about the shared decision‑making process are
required to evaluate patient preference and treatment
outcome.
There were limitations to this study. First, although
we tried to provide the best available information on
EUS‑BD, our data were limited in terms of the safety
54

profile and efficacy of EUS‑BD, which impaired the
patients’ ability to make an informed choice. For this
reason, we evaluated patient preference according to
whether AE rates were higher or lower than PTBD (9%–
33%). Second, we did not specifically query patients
regarding the type of prior endoscopy (gastroscopy vs.
colonoscopy), ERCP (diagnostic vs. therapeutic), and
PTBD (single vs. multiple) that they had previously
undergone. This may have influenced patient perception
of EUS‑BD, as their preference could have been based
on their previous procedural experience. Third, we did
not confirm whether the patients sufficiently grasped
the concept of EUS‑BD. Although the informational
booklet and questionnaire were written in an easily
understandable language, patients with older age and a
lower educational level might not have understood the
questions. Finally, although the questionnaire was tested
for internal consistency before its administration, it was
not fully independently validated because this was a
pilot study on patient preference. Medical students may
not have been an accurate representation of the general
patient population that was scheduled to undergo BD for
malignant biliary obstruction.
CONCLUSIONS
In this international multicenter survey, approximately
80% of the patients preferred EUS‑BD to PTBD
after being informed of the benefits and risks of both
procedures. However, preference of EUS‑BD declined
as its AE rates increased. Although our survey data
are preliminary, patients had favorable perception of
EUS‑BD due to the possibility of internal drainage
without a percutaneous drain tube. Further technical
innovations and improved proficiency in EUS‑BD
for reducing AEs may increase patient preference of
EUS‑BD and encourage the use of this procedure as a
routine clinical practice when ERCP fails.
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SUPPLEMENTARY APPENDICES

Supplementary Appendix 1
Patient perception and preference of EUS-guided
drainage over percutaneous drainage when endoscopic
transpapillary biliary drainage fails: an international
multicenter survey.
Subject: A survey for the patient perception and
preference between draining the bile by placing a
biliary catheter through the skin (called percutaneous
transhepatic biliary drainage, PTBD) and draining
the bile by the use of endoscopy with the help
of ultrasonography (called EUS biliary drainage,
EUS-BD) in patients with biliary obstruction after
unsuccessful biliary drainage with ERCP-guided
biliary drainage (ERCP-BD).
When obstructive jaundice occurs in patients with
biliary obstruction, the bile is drained by the use of
special endoscope called ERCP-BD during which
they place a drainage catheter in the bile duct by
passing the scope from the mouth to the small bowel
then to the bile duct, it is considered as the first
treatment option. Its success rate is approximately
95%, whereas its adverse event rate ranges from 1%5%. If this procedure fails due to duodenal invasion
by tumor or prior surgery, there are two alternative
treatment options, which are:
1- Draining the bile by placement of biliary drainage
catheter through the skin (called percutaneous
transhepatic biliary drainage, PTBD);
2- Draining the bile by another special endoscope with
the help of ultrasonography (called EUS- guided biliary
drainage, EUS-BD).
1. Draining the bile by placing a biliary catheter
through the skin (percutaneous transhepatic biliary
drainage, PTBD)
PTBD is a procedure to drain the bile ducts through
the skin of a patient with obstruction in the bile duct.
The classic biliary drainage procedure is performed by
the use of special screen, a special dye and an X-ray
(called fluoroscopy). During this procedure the skin
is injected with local anesthesia then a guide needle
and biliary drainage catheter is inserted below the
right 10th rib. The procedure takes about 30 minutes

to1 hour. It is a standard treatment for benign or
malignant obstruction in the bile duct after failed
draining with ERCP (ERCP-BD). Its success rate
ranges from 87% to 100%. The overall incidence of
adverse events is about 13% (range 9%-33%). These
adverse events include infection, bleeding, and catheter
blockage or movement to a different location. The
overall incidence of severe adverse event is 8.2%
(bile duct injury, and severe bleeding in the bile
duct or abdominal cavity) When massive bleeding
occurs, emergent procedure will be required such as
closing the bleeding vessels by the radiologist with
the use of special dye and X-ray (called angiogram)
or surgery. The advantage of this procedure is high
success rate with relatively shorter procedure time
and it is well-established procedure (which has been
done successfully many times in the past) after failed
ERCP. The disadvantages of this procedure are related
to the draining catheter and the canal formed by this
catheter, which is related to pain, dislodgment, and
tract implantation with tumor in cancer patients.
2. Endoscopic drainage of bile with the help of
ultrasonography (EUS-guided biliary drainage,
EUS-BD)
EUS is a type of endoscopy with an ultrasonogram
attached to the front of the scope. Using EUS,
the gastroenterologist can examine the parts which
cannot be seen with the usual endoscope. EUS
guided biliary drainage is a newly developed procedure
used in bile duct obstr uction caused by cancer
during which a new drainage route is made either by
making a route between the liver and the stomach
(called hepaticogastrostomy, EUS-HG) or making
a route between the bile duct and the duodenum
(called choledochoduodenostomy, EUS-CD). It is
a newly developed procedure, and its success rate
ranges from 75% to 100%, which is comparable
to draining the bile through the skin (percutaneous
transhepatic biliary drainage, PTBD). The overall
incidence of adverse event ranges from 11% to
27%. These adverse events includes leakage of
bile to the abdominal cavity causing inflammation
(Bile peritonitis), stent migration to a different
location, self-limited air leak to the abdominal cavity
(Pneumoperitoneum), and bleeding. The advantages
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of this procedure are that it can be done at the
same time after failed ERCP (bile drainage through
the skin by catheter placement PTBD is mostly
performed in another session after failed ERCP).
Furthermore, no external drain is required. Based on
recent studies, the technical and clinical success rate
and incidence of overall adverse event is comparable
to draining the bile through the skin (PTBD). The

disadvantages of this procedure are that it is a
relatively new approach, which should be performed
by an expert gastroenterologist. Thus, the overall
success and adverse event rate may vary based on the
gastroenterologist experience in this field.
*Cost includes only basic procedure and additional cost
about stent insertion is possible.

Table 1. The comparison of ERCP-BD, PTBD, EUSBD
ERCP-BD*

PTBD*

EUS-BD*

Summary

Using ERCP,
insert biliary
drainage
catheter from
inside the
small bowel

Procedure
Time
Cost*

30 minutes
– 1 hour
(Outpatient)

Using EUS,
make a
new biliary
drainage
route (liverstomach,
bile ductduodenum)
Within 1 hour

Success Rate
Adverse
Event Rate

90%-97%
<10%

Advantages

Allows
diagnosis and
treatment
simultaneously.
Bile drain
inside

Disadvantages

Difficulty to
approach
the bile duct
from inside
in case of
some cancer
or surgically
altered
anatomy.
Possibility of
bleeding or
infection in
the bile duct.

Using special
X-ray called
fluoroscopy to
insert biliary
drainage
catheter
through
the skin
30 minutes
– 1 hour
(Outpatient)1
x ERCP-BD
87%-100%
9%-33%
(Mortality
Rate 2%-15%)
Shorter
procedure
time, less
procedurerelated pain
Bile drain
outside by
catheter
through
the skin.
Bile drains
outside by
catheter
through the
skin, some
problems with
drain care.
Possibility of
bleeding or
infection in
the bile duct.

(Outpatient)
1.5 x ERCP-BD
75%-100%
~25%

Bile drainage by ERCP (ERCP-BD)

Allows
immediate
procedure
after failed
endoscopic
procedure.
Bile drain
inside

Operatordependent
procedure
needs
experiences.
Possibility
of infection
in abdomen
(peritonitis),
stent
migration.

*ERCP-BD, ERCP-guided biliary drainage; PTBD, percutaneous transhepatic
biliary drainage; EUS-BD, EUS guided biliary drainage.

Bile catheter placement through the skin (PTBD)
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Bile drainage by EUS (EUS-BD)

Supplementary Appendix 2
Patient perception and preference of EUS-guided drainage over percutaneous drainage when endoscopic
transpapillary biliary drainage fails: an international multicenter survey.
We will ask you some questions about your preference for draining the bile through the skin (PTBD) or by the
use of endoscopy with ultrasonography (EUS-BD) if ERCP drainage fails.
Please provide the following information
- Age: (Year of the Birth: 19____)- Sex: Male / Female
- Race: Caucasian, Hispanic, Asian, etc (____________)
- Did you have an endoscopy before? Yes / No
- Did you have an upper endoscopy before, where they looked at your bile duct or pancreas (called ERCP) before?
Yes / No
- Did you have bile drain placed through the skin (called PTBD) before? Yes / No
Question 1)
- If you should choose to have a bile drain placed, after failing ERCP drainage, would you prefer the drain placed
through the skin (PTBD) or you prefer the drainage by EUS (EUS-BD)
(Circle one)
a) Through the skin (PTBD)
b) By EUS (EUS-BD)
- If you chose to have a bile drain placed, after failing ERCP drainage, would you prefer the drainage through
the skin (PTBD) if
(Circle all that apply)
a) It takes less time to place it (quicker)
b) It is cheaper
c) It is safer (lower adverse events)
d) It is more convenient (easy to perform for operator)
e) Other: ___
- If you chose to have a bile drain placed, after failing ERCP drainage, would you prefer drainage by EUS (EUSBD) if
(Circle all that apply)
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a) It can be done at the same time during the ERCP, so you do not have to come back again for another procedure
b) It has a higher success rate and relatively low adverse events
c) It is comfortable, so you do not have drain tube through the skin (such as PTBD)
d) Other: ___________________________
Question 2)
Would you prefer a drain placed through the skin if,
(Choose Yes/No in each)
(a) It is safer than EUS drainage (EUS-BD)
(b) It is more dangerous than EUS drainage (EUS-BD)
(c) It has the same risk like EUS drainage (EUS-BD)

Yes/No
Yes/No
Yes/No

Supplementary Appendix 3
The results of pilot test for 34 medical students
Table 1. Preference of biliary drainage when
ERCP fails and the reason for their preference
Total
Prefer EUS‑BD
Less physical discomfort (no
percutaneous drain tube)
Higher success rate with lower morbidity
One‑stage procedure when ERCP failed
Prefer PTBD
Proven technical safety
Shorter procedure time
Technical easiness
Low cost

34 (100.0%)
29/34 (85.3%)
26/29 (89.7%)
10/29 (34.5%)
15/29 (51.7%)
5/34 (14.7%)
3/5 (60.0%)
3/5 (60.0%)
2/5 (40.0%)
0/5 (0.0%)

Trend of the preference for EUS-BD with varying adverse event rated for EUS-BD (n = 34)

Preference for EUS-BD (%)
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Supposed adverse event rate of EUS-BD (%)

